Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Income towards Parent Company: 2011-2012

Historic Income towards Parent Company for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$7.4 million.

  • Sonoma Pharmaceuticals' Income towards Parent Company rose 63.49% to -$954,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.6 million, marking a year-over-year increase of 36.33%. This contributed to the annual value of -$7.4 million for FY2012, which is 6.50% up from last year.
  • According to the latest figures from FY2012, Sonoma Pharmaceuticals' Income towards Parent Company is -$7.4 million, which was up 6.50% from -$7.9 million recorded in FY2011.
  • Sonoma Pharmaceuticals' 5-year Income towards Parent Company high stood at -$7.4 million for FY2012, and its period low was -$7.9 million during FY2011.
  • Its 2-year average for Income towards Parent Company is -$7.7 million, with a median of -$7.7 million in 2011.
  • Data for Sonoma Pharmaceuticals' Income towards Parent Company shows a peak YoY rose of 6.50% (in 2012) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' Income towards Parent Company (Yearly) stood at -$7.9 million in 2011, then climbed by 6.50% to -$7.4 million in 2012.